Healthy Clinical Trial
Official title:
Effects of Test Meal Volume and Energy Density on Gastric Volumes and Satiety Assessed by MRI
The GI MRI Research group at the University of Nottingham has been developing new, non-invasive magnetic resonance imaging (MRI) techniques to image the gastrointestinal tract. In collaboration with food manufacturer Unilever, the investigators want to image the abdomen of healthy volunteers after consumption of test meals of varying volume and energy density to determine levels of gastric distension and investigate possible correlations of this with the subjects' sense of satiety.
| Status | Completed |
| Enrollment | 18 |
| Est. completion date | December 2012 |
| Est. primary completion date | December 2012 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Male |
| Age group | 18 Years to 60 Years |
| Eligibility |
Inclusion criteria: - Apparently healthy; no medical conditions that might affect the study measurements (as determined by the study physician) - No use of medication that would interfere with the study measurements (as determined by the study physician) - No use of antibiotics in the 3 months before the study or during the study - No reported participation in another nutritional or biomedical trial 3 months before the study or during the study - Being used to eating 3 meals daily - BMI: 20 - 35 kg m-2 - No reported participation in night shift work 2 weeks prior to the study or during the study - Not taking part in strenuous exercise =10 hours/week - Not consuming more than 21 alcoholic test meals in a typical week - Not presently a smoker - No reported weight loss or gain of more than 10 % of bodyweight for 6 months before the study - No eating disorder - No MRI contraindications; i.e absence of metal implants, infusion pumps and pacemakers, as assessed by a MRI safety screening questionnaire Exclusion criteria: - High or very high restrained eater - Use of any medically- or self-prescribed diet for the duration of the study - Allergies or food intolerances |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Basic Science
| Country | Name | City | State |
|---|---|---|---|
| Netherlands | Unilever Research and Development | Olivier van Noortlann 120 | AT Vlaardingen |
| United Kingdom | Nottingham Digestive Diseases Centre and Sir Peter Mansfield Magnetic Resonance Centre | University of Nottingham | Nottingham |
| Lead Sponsor | Collaborator |
|---|---|
| University of Nottingham | Unilever R&D |
Netherlands, United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Relationship of gastric behaviour of test meal stomach volumes with satiety | A comparison of the gastric volumes with satiety scores obtained throughout the experiment | 0 - 240 minutes | No |
| Primary | Total gastric content half emptying time T50 | Total gastric volume at half the experimental time | 0 - 240 mins | No |
| Secondary | Volumes of test meal in the stomach | gastric volumes of the test meals in the stomach obtained from MRI images, as a function of time | 0 - 240 mins | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |